ArticleFrontiers in oncology2019

Germline Polymorphisms in the Nuclear Receptors PXR and VDR as Novel Prognostic Markers in Metastatic Colorectal Cancer Patients Treated With FOLFIRI.

Elena De Mattia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.